SCHEMBL432576

SCHEMBL432576

CC1CC(CC2CC(C)C(N)C(C)C2)CCC1N

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.30
MC5R P33032 1/20 0.30
MC3R P41968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26046665 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL25475301 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL22667642 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL24896181 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL18473955 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL25475337 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL16007998 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL25475320 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL21699924 0.91 MC4R (0.32) MC4RMC5RMC3R
SCHEMBL27331 0.91 MC4R (0.32) MC4RMC5RMC3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080226845-A1 Polyamic acid-based composition and liquid crystal orienting film DAILY POLYMER CO., LTD. 2008-09-18 US claimed
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures COVESTRO DEUTSCHLAND AG (DE) 2026-02-24 US disclosed
EP-3938416-B1 POLYURETHANE COATING COMPOSITIONS AND THEIR USE AS GEL COATS COVESTRO LLC (US) 2025-09-10 EP disclosed
CN-115605525-B Uretdione-containing compositions that crosslink at low temperatures 科思创德国股份有限公司 2025-01-10 CN disclosed
EP-4277941-B1 COMPOSITIONS CONTAINING URETDIONE GROUPS COVESTRO DEUTSCHLAND AG (DE) 2025-01-01 EP disclosed
CN-113710717-B Latent reactive adhesive formulations 科思创德国股份有限公司 2024-11-15 CN disclosed
EP-4157912-B1 COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES COVESTRO DEUTSCHLAND AG (DE) 2024-05-22 EP disclosed
EP-3959251-B1 LATENT REACTIVE ADHESIVE PREPARATIONS COVESTRO DEUTSCHLAND AG (DE) 2024-03-27 EP disclosed
EP-3129353-B1 METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE COVESTRO DEUTSCHLAND AG (DE) 2024-02-28 EP disclosed
EP-4277941-A1 COMPOSITIONS COMPRISING URETDIONES Covestro Deutschland AG (DE) 2023-11-22 EP disclosed
US-5710230-A REACTION INJECTION MOLDING; POLYURETHANE-POLYUREA MOLDING BAYER CORPORATION (US) 1998-01-20 US disclosed
US-5668239-A High modulus, high impact polyurethane/polyurea RIM BAYER CORPORATION (US) 1997-09-16 US disclosed
US-5663272-A STORAGE STABLE LIQUID MADE FROM DIPHENYLMETHANE DIISOCYANATE AND MONOISOCYANATES BAYER CORPORATION (US) 1997-09-02 US disclosed
US-5607998-A Process for the repair of plastic parts using non-sagging, sandable polyurethane compositions BAYER CORPORATION (US) 1997-03-04 US disclosed
US-5502147-A POLYURETHANES BAYER CORPORATION (US) 1996-03-26 US disclosed
EP-0659792-A2 Aliphatic polyurethane RIM elastomers Bayer Corporation (US) 1995-06-28 EP disclosed
US-4764543-A Microcellular foamed or reaction injection molded polyurethane/polyureas employing amine terminated polymers and diamine chain extenders THE DOW CHEMICAL COMPANY (US) 1988-08-16 US disclosed
US-4384052-A Polyurethanes produced from an adduct of an organic polyisocyanate and certain amines BASF WYANDOTTE CORPORATION (US) 1983-05-17 US disclosed
US-4210728-A Preparation of high resiliency polyurethane foams BASF WYANDOTTE CORPORATION (US) 1980-07-01 US disclosed
EP-0003954-A1 Reactive polyol compositions and high resiliency polyurethane foams obtained by using these compositions BASF WYANDOTTE CORPORATION (US) 1979-09-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures URB2, UQCRB, UQCRC2 MC4R 1732/4885MC5R 863/4885MC3R 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.